综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

BIZCHINA> Top Biz News
Drug maker Sanjiu's profits surge 87% in 2008
By Tong Hao (chinadaily.com.cn)
Updated: 2009-03-16 18:32

Sanjiu Medical & Pharmaceutical Co posted an 87 percent surge in its net profits in 2008.

Related readings:
Drug maker Sanjiu's profits surge 87% in 2008 Pharma stocks offer new hope 
Drug maker Sanjiu's profits surge 87% in 2008 China will spend 850b yuan on medical care reform, Wen says
Drug maker Sanjiu's profits surge 87% in 2008 China to boost spending on welfare, medicare
Drug maker Sanjiu's profits surge 87% in 2008 
Minister: Healthcare network to cover all

Business revenue of the Shenzhen-based company increased by 24 percent to 4.32 billion yuan ($632 million) in 2008, realizing a profit of 500 million yuan, according to the annual financial report the company filed to the Shenzhen Stock Exchange on March 14.

Sanjiu forecasted its business revenue to increase by 6.74 percent to 4.6 billion yuan in 2009, which would mean a net profit of 650 million yuan.

The report said Sanjiu would expand its business scope through mergers and acquisitions, speed its pace in launching new products and enlarge its market share in areas below county level.

The report said business revenue of its pharmaceutical operations increased by 18.8 percent.

In 2008, many industries in China such as textile and auto were seriously hit by the global financial crisis. However, the gross output value of China's pharmaceutical industry increased by 25 percent, reaching 791.2 billion yuan, and the market size increased by 21.4 percent to 464.2 billion yuan, according to statistics in the report.

"Pharmaceutical industry doesn't have much connection with macroeconomic fluctuation because demand for medical care keeps stable. People need medicine when they get sick," said Yao Jie, an industrial analyst with Everbright Securities.

Sanjiu estimates the country's pharmaceutical industry will continue to grow in coming years due to the impending government reform of the medical care system.

China has announced an 850-billion-yuan investment in the country's medical care system reform in the next three years.

"The reform will spur medicine consumption; thus the pharmaceutical industry in China will maintain a fast-developing pace in the long run," Yao said.

He added that pharmaceutical companies in China should also pay more attention to research and development, saying that the Chinese pharmaceutical industry lags behind in R&D compared with foreign competitors.


(For more biz stories, please visit Industries)

 

 

平遥县| 望江县| 开原市| 安康市| 四子王旗| 临颍县| 庆云县| 会宁县| 慈利县| 湖北省| 纳雍县| 普陀区| 吉木萨尔县| 鄂托克前旗| 新密市| 宝坻区| 台南市| 崇礼县| 芜湖市| 襄垣县| 洛宁县| 博兴县| 兴山县| 克拉玛依市| 洞头县| 炉霍县| 建宁县| 张家界市| 绍兴市| 元朗区| 旺苍县| 藁城市| 青田县| 临泽县| 讷河市| 宜川县| 岫岩| 宣武区| 阿勒泰市| 灵寿县| 海晏县|